SCHEMBL7154000

SCHEMBL7154000

CCCCNc1ccc(C(F)(F)F)cc1C(=O)NC(C=O)C(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.42
PLK1 P53350 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
LIPC P11150 1/20 0.38
LIPG Q9Y5X9 1/20 0.38
MAPT P10636 5/20 0.38
THRB P10828 1/20 0.38
CCR2 P41597 4/20 0.38
CCR5 P51681 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38
ALDH1A1 P00352 2/20 0.37
RXFP1 Q9HBX9 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7168919 0.81 RXFP1 (0.41) L3MBTL1PLK1NPSR1MAPTALDH1A1
SCHEMBL3888029 0.78 LIPC (0.60) L3MBTL1PLK1HDAC3HDAC1HDAC2
SCHEMBL7109974 0.77 RXFP1 (0.51) PLK1NPSR1MAPTCCR2CCR5
SCHEMBL7112858 0.77 CCR2 (0.44) CCR2ALDH1A1
SCHEMBL7109818 0.74 RXFP1 (0.51) CCR2TSHRALDH1A1RXFP1GAA
SCHEMBL7155398 0.71 TRPA1 (0.50) HDAC3HDAC1HDAC2NPSR1CCR2
SCHEMBL3888815 0.70 LIPC (0.63) PLK1LIPCLIPGCYP1A2ALDH1A1
SCHEMBL14015050 0.69 L3MBTL1 (0.51) L3MBTL1PLK1HDAC3HDAC1HDAC2
SCHEMBL7107168 0.68 TRPA1 (0.45) NPSR1CCR2CYP1A2TAS1R3TAS1R1
SCHEMBL16737192 0.67 PLK1 (0.53) PLK1LIPCLIPGSMN1; SMN2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1351924-A2 DIAMINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Pharma Company (US) 2003-10-15 EP claimed
WO-2002050019-A2 DIAMINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB PHARMA CO. (US) 2002-06-27 WO claimed